IMMUNE PHARMACEUTICALS INC's ticker is IMNP and the CUSIP is 45254C101. A total of 14 filers reported holding IMMUNE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $43,000 | – | 152,498 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TWO SIGMA SECURITIES, LLC | 158,998 | $29,000 | 0.01% |
| Geduld E E | 25,000 | $5,000 | 0.00% |
| UBS Group AG | 100,064 | $18,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 27,500 | $5,000 | 0.00% |
| Advisor Group, Inc. | 75,000 | $14,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 447,068 | $81,000 | 0.00% |
| DEUTSCHE BANK AG\ | 28 | $0 | 0.00% |
| GOLDMAN SACHS GROUP INC | 36,225 | $7,000 | 0.00% |
| VANGUARD GROUP INC | 3,981,879 | $725,000 | 0.00% |
| BlackRock Fund Advisors | 8,931 | $2,000 | 0.00% |